» Articles » PMID: 33817092

Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review

Overview
Journal Open Life Sci
Specialty Biology
Date 2021 Apr 5
PMID 33817092
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Object: To summarize the etiology, pathology, diagnosis, clinical features, and treatment of the rare extranodal Rosai-Dorfman disease (RDD).

Methods: Clinical data of three cases of extranodal RDD who were admitted to the E. N. T. Department of the second hospital of Jilin University were analyzed retrospectively, and the literature was reviewed.

Results: Three cases of extranodal RDD (maxillary sinus, nasal pharyngeal focus, and external auditory meatus) had a low fever and weight loss rather than painless enlarged lymph nodes. Surgical intervention was managed to clarify the diagnosis. All pathological diagnoses were extranodal RDD. Predisone for oral use was given to all patients postoperatively. There was no recurrence in the following 3 months, except case 1 was lost 2 months later.

Conclusions: RDD is a rare idiopathic histiocytic proliferative disorder defined by its unique histopathological features: a proliferation of huge histiocytic cells with emperipolesis and S-100(+), CD1a(-). RDD is characterized clinically by bilateral cervical painless enlarged lymph nodes, while extranodal RDD is rarer and its manifestations varied. A defined therapeutic regimen has not been elucidated. RDD in about 20% of patients is self-limited. Surgical intervention is the main management of treatment, with glucocorticoids used in initial medical therapy. More clinical trials are necessary before drawing conclusions.

Citing Articles

Potential role of F-FDG PET/CT in a case of progressive Rosai Dorfman disease.

Fard-Esfahani A, Saidi B, Seyedinia S, Emami-Ardekani A, Eftekhari M Asia Ocean J Nucl Med Biol. 2021; 9(1):62-66.

PMID: 33392352 PMC: 7701221. DOI: 10.22038/AOJNMB.2020.51742.1356.

References
1.
Aradhana K, Thejaswini B, Shamsundar A, Nanda R, Amritham U, Giri G . Rosai-Dorfman Disease - Five Years Retrospective Analysis from Tertiary Cancer Center. Gulf J Oncolog. 2018; 1(26):11-17. View

2.
Chen Y, Jiang X, Lu J, Zhang H, Li X, Chen G . [Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases]. Zhonghua Bing Li Xue Za Zhi. 2016; 45(8):556-60. DOI: 10.3760/cma.j.issn.0529-5807.2016.08.012. View

3.
Xu Q, Fu L, Liu C . Multimodality imaging-based evaluation of Rosai-Dorfman disease in the head and neck: A retrospective observational study. Medicine (Baltimore). 2018; 96(51):e9372. PMC: 5758235. DOI: 10.1097/MD.0000000000009372. View

4.
Garces S, Medeiros L, Patel K, Li S, Pina-Oviedo S, Li J . Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol. 2017; 30(10):1367-1377. PMC: 5837474. DOI: 10.1038/modpathol.2017.55. View

5.
Arnao V, Riolo M, Savettieri G, Aridon P . Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease. Case Rep Neurol Med. 2016; 2016:1030478. PMC: 5093240. DOI: 10.1155/2016/1030478. View